474 — Aceso Life Science Share Price
Last Trade - 00:00- HK$1.39bn
- HK$2.63bn
- HK$346.00m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Mar | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 206.31 | 330.02 | 319.51 | 295.64 | 346 | n/a | n/a | 21.63% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aceso Life Science Group Ltd, formerly Hao Tian Development Group Ltd, is an investment holding company mainly engaged in the sale of construction machineries and spare parts. The Company operates its business through five segments. The Trading of Construction Machinery, Spare Parts and Construction Materials segment engages in the trading of construction machineries, spare parts and building materials, and the provision of construction machinery rental services. The Provision of Repair and Maintenance Service segment provides repair and maintenance services for construction machineries. The Provision of Transportation Service segment provides mechanical transportation services. The Provision of Asset Management, Securities Brokerage Commodities, Futures and Other Financial Services engages in securities and futures trading, asset management, wealth management, financing and precious metal business. The Retailing of Men’s and Women’s Apparels segment engages in the sale of apparels.
Directors
- Chi Tak Fok CFO (41)
- Chan Lai Ping
- Zhiliang Ou EDR (46)
- Hai Ying Xu EDR (63)
- Yao Li (51)
- Yu Wang (62)
- Ming Sun Chan (48)
- Kwan Sing Lam (49)
- Chi Hwa Lee (48)
- Last Annual
- March 31st, 2021
- Last Interim
- March 31st, 2021
- Incorporated
- September 30th, 2005
- Public Since
- June 6th, 2006
- No. of Employees
- 175
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 6,932,000,000
- Address
- Unit 4803, 48/F, COSCO Tower
- Web
- http://www.acesogrouphk.com/
- Phone
- +852 null31608466
- Auditors
- ZHONGHUI ANDA CPA Limited
Latest News for 474
Upcoming events for 474
Hao Tian Development Group Ltd Annual Shareholders Meeting
Similar to 474
KAISA CAPITAL ORD
Stock Exchange of Hong Kong Limited
TAK LEE MACH ORD
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:56 UTC, shares in Aceso Life Science are trading at HK$0.20. This share price information is delayed by 15 minutes.
Shares in Aceso Life Science last closed at HK$0.20 and the price had moved by -41.74% over the past 365 days. In terms of relative price strength the Aceso Life Science share price has underperformed the FTSE Developed Asia Pacific Index by -54.09% over the past year.
There is no consensus recommendation for this security.
Aceso Life Science does not currently pay a dividend.
Aceso Life Science does not currently pay a dividend.
Aceso Life Science does not currently pay a dividend.
To buy shares in Aceso Life Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.20, shares in Aceso Life Science had a market capitalisation of HK$1.39bn.
Here are the trading details for Aceso Life Science:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 474
Based on an overall assessment of its quality, value and momentum Aceso Life Science is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aceso Life Science. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -12.81%.
As of the last closing price of HK$0.20, shares in Aceso Life Science were trading -12.78% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Aceso Life Science.
Aceso Life Science's management team is headed by:
- Chi Tak Fok - CFO
- Chan Lai Ping -
- Zhiliang Ou - EDR
- Hai Ying Xu - EDR
- Yao Li -
- Yu Wang -
- Ming Sun Chan -
- Kwan Sing Lam -
- Chi Hwa Lee -
We do not have data on Aceso Life Science's shareholders